answersLogoWhite

0

There are several reasons. First, everyone else is--Pfizer just bought Wyeth, for instance. Second, the two companies have complimentary portfolios of prescription medicines, many of which are about ready to come off patent, and they don't have a massive amount of new products in the pipeline. Drugs are very expensive to bring to market, and they're starting to run out of new diseases to develop drugs to treat. Merck benefits here because Schering-Plough has a lot more drugs that aren't about to go off-patent than Merck does, and Schering-Plough has animal health and consumer health divisions Merck needs. Schering-Plough benefits because Merck is exceptionally well-funded and they have a vaccine business S-P needs. All is not happiness and joy, though; the merger is going to shed about 15,000 workers.

User Avatar

Wiki User

16y ago

What else can I help you with?

Related Questions

What does merck sell?

Merck & Co. is an american pharmaceutical company.


Did the government create ecstasy?

No. Merck, the German pharmaceutical company invented MDMA in the early 1900s.


Did ecstasy come from a German company?

yes ... žMDMA was first synthesised by a German chemist in 1914 is was controlled by Merck Pharmaceutical Company


What sort of company is Merck Serono?

Merck Serono is the name of a pharmaceutical company based in Switzerland. In the United States and Canada, it is known as EMD Serono. It was formed in 2006 by a merger between Merk and the smaller Serono corporation.


When was Merck Index created?

The Merck Index, a comprehensive resource of chemical compounds and information, was first published in 1889 by the pharmaceutical company Merck. It has since undergone multiple editions and revisions to keep up with new discoveries and research in chemistry.


Which pharmaceutical co makes losartan?

Lupin


Who makes Fosamax?

Fosamax is made by Merck & Co., Inc., a pharmaceutical company headquartered in the United States. It is used to treat osteoporosis and other bone-related conditions.


How much is the American pharmaceutical giant Merck paying to buy its rival Schering-plow?

Merck & Co. is buying Schering-Plough Corp. for $41.1 billion.


What does MERCK stand for?

Nothing, Assuming you are referring to Merck & Co. Merck is a drug company, that is it's name. It is not an acronym.


What was Merck first IPO?

Merck & Co., Inc. went public in 1946, marking its first initial public offering (IPO). The company issued 1.2 million shares at a price of $40 per share to raise capital for expansion and development. This IPO helped Merck establish itself as a significant player in the pharmaceutical industry. Over the years, the company's growth and innovation have solidified its position as a leading global healthcare firm.


Which pharmaceutical companies are most relied on for new treatments for depression?

Merck is a pharmacutical company that is known for helping those with depression and other mental illnesses. Generic is cheaper though and has the same effectiveness.


When did Raymond Gilmartin first go to work for Merck?

In 1994 Gilmartin was recruited to be the new president and chief executive officer of Merck, the large pharmaceutical firm headquartered in New Jersey.